SAN FRANCISCO, CALIFORNIA, Feb. 25, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback